Sector revisions Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 04:00:02 2026-09-01 pm EDT			5-day change	1st Jan Change
380.96 ^USD	-1.34%		-2.40%	+25.73%

Aug. 07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
Aug. 05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	BIO-RAD LABORATORIES, INC.							5
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	DEXCOM, INC.							25
	MEDLINE INC.							26
	WEST PHARMACEUTICAL SERVICES, INC.							15
	TERUMO CORPORATION							13
	STERIS PLC							8
	SARTORIUS STEDIM BIOTECH							14
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	ALIGN TECHNOLOGY, INC.							15
	GLOBUS MEDICAL, INC.							13
	INSULET CORPORATION							22
	REPLIGEN CORPORATION							20
	Average							16
	Weighted average by Cap.							19